Tesla stock was little changed early Wednesday as investors waited for the company’s AI-trained humanoid robot, Optimus. Tesla stock was down 16 cents at $421.80 in premarket trading, while and futures were up 0.3% and 0.2%, respectively. Tesla’s Optimus robot won in a landslide, beating out the Cybercab, semi-truck, and stationary storage.
Tesla stock was little changed early Wednesday as investors waited for the company’s AI-trained humanoid robot, Optimus. Tesla stock was down 16 cents at $421.80 in premarket trading, while and futures were up 0.3% and 0.2%, respectively. Tesla’s Optimus robot won in a landslide, beating out the Cybercab, semi-truck, and stationary storage.
(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, semiconductor maker Vishay Intertechnology, Inc. (VSH) said it expects revenues for the first quarter in a range of $800 million to $830 million. On average, analysts polled expect the company to report revenue of $804.80 million for the quarter. In Wednesday's pre-market trading, VSH is trading on the NYSE at $20.2...
(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, semiconductor maker Vishay Intertechnology, Inc. (VSH) said it expects revenues for the first quarter in a range of $800 million to $830 million. On average, analysts polled expect the company to report revenue of $804.80 million for the quarter. In Wednesday's pre-market trading, VSH is trading on the NYSE at $20.23, down $0.50 or 2.41 percent. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Michael Vi/iStock Editorial via Getty Images Shares of Skyworks Solutions ( SWKS ) rose about 3% premarket on Wednesday after fiscal first quarter results and outlook beat estimates, drawing positive reactions from analysts. J.P. Morgan kept its Neutral rating on Skyworks but lowered the price target to $65 from $74. The firm said Skyworks's solid results and guidance reflect strong iPhone demand,...
Michael Vi/iStock Editorial via Getty Images Shares of Skyworks Solutions ( SWKS ) rose about 3% premarket on Wednesday after fiscal first quarter results and outlook beat estimates, drawing positive reactions from analysts. J.P. Morgan kept its Neutral rating on Skyworks but lowered the price target to $65 from $74. The firm said Skyworks's solid results and guidance reflect strong iPhone demand, adding that flat content growth at Apple was better than feared. "Skyworks’ Dec-Qtr results came in better than consensus, reflecting strong iPhone unit shipments trends alongside continued growth in the Broad Markets segment. For the Mar quarter outlook, management expects revenue to decline 6% Q/Q, better than expectations, driven by a 20% decline in the mobile business, while Broad Markets is expected to be flattish Q/Q. Regarding its main customer, Apple ( AAPL ), iPhone momentum remains strong," said analysts led by Peter Peng. The analysts noted that Skyworks expects blended content to be flat year-over-year for the upcoming iPhone cycle — better than feared, given market concerns about further content loss. The analysts added that Skyworks is seeing strong demand signals from its lead customers, and while there are concerns about higher memory pricing potentially affecting smartphone demand, no such impact has been seen yet. "That said, we are concerned about demand destruction on higher memory prices in 2H of this year. Outside of Apple, the Android business declined Q/Q in the December quarter but is expected to grow double digits Q/Q in the Mar-Qtr. We anticipate Google’s ( GOOG ) ( GOOGL ) business will remain strong, while Samsung ( SSNLF ) is expected to decline," said Peng and his team. The analysts noted that Broad Markets segment continues to gradually improve, with eight consecutive quarters of modest growth led by WiFi 7, automotive, and data centers. "We continue to view the acquisition of Qorvo favorably, as it should drive scale and diversification ben...
Far be it from me to offer up a differing perspective than the almighty AI chip god more formally known as Nvidia (NVDA) founder and CEO Jensen Huang. But this one time as it pertains to the AI stock rout we are witnessing, I must "push back" on the often leather jacket clad Big J. "There's this notion that the tool in the software industry is in decline, and will be replaced by AI ... It is the ...
Far be it from me to offer up a differing perspective than the almighty AI chip god more formally known as Nvidia (NVDA) founder and CEO Jensen Huang. But this one time as it pertains to the AI stock rout we are witnessing, I must "push back" on the often leather jacket clad Big J. "There's this notion that the tool in the software industry is in decline, and will be replaced by AI ... It is the most illogical thing in the world, and time will prove itself," Huang reportedly said at an AI event that router giant Cisco (CSCO) held on Tuesday. "If you were a human or robot, artificial, general robotics, would you use tools or reinvent tools? The answer, obviously, is to use tools ... That's why the latest breakthroughs in AI are about tool use, because the tools are designed to be explicit." At this crucial moment for tech investors, the market can care less what Jensen has to say on this topic. Sure, Jensen is often the one that stirs the drink in markets in part because Nvidia is the one that stirs the drink in markets. But the market fully believes software companies such as Salesforce (CRM), Workday (WDAY), Thomson Reuters (TRI), SAP (SAP), and ServiceNow (NOW) have their terminal values at risk because of quick-developing advancements of AI. Just look at what Anthropic (ANTH.PVT) debuted on Friday (which initially flew a little under the radar), which sparked another software rout on top of the rout we had already seen in 2026. The AI developer debuted plug-ins for its Claude Cowork agent that could automate tasks across legal, sales, marketing and data analysis. By the close of trading on Tuesday, shares of Thomson Reuters, Legalzoom.com (LZ), PayPal (PYPL), Expedia Group (EXPE), Equifax (EFX), and Intuit (INTU) had all crashed by double-digit percentages. There is minimal nibbling at these names today on the deep pullback. The overall US Software index fell nearly 5%, and saw 104 decliners and only 9 risers. The drop marked its sixth successive decline to put...
Kinaxis ( KXS:CA ) on Wednesday said that it plans to amend its normal course issuer bid to increase the number of shares it is permitted to repurchase to about 2.8 million, representing 10% of its public float, the maximum allowed under Toronto Stock Exchange rules. The proposed increase would raise the buyback limit from 1.40 million shares, or 5% of shares outstanding as of October 31, 2025. Ki...
Kinaxis ( KXS:CA ) on Wednesday said that it plans to amend its normal course issuer bid to increase the number of shares it is permitted to repurchase to about 2.8 million, representing 10% of its public float, the maximum allowed under Toronto Stock Exchange rules. The proposed increase would raise the buyback limit from 1.40 million shares, or 5% of shares outstanding as of October 31, 2025. Kinaxis has already spent about $54 million under the current program. Based on the average price paid to date, repurchasing the full 10% would require an additional investment of roughly $284 million, the company said. As of February 3, Kinaxis had repurchased 447,738 shares at an average price of C$167.50 per share. The buyback program began on November 12, 2025, and runs until November 11, 2026, subject to earlier completion or termination. The amendment to the buyback program is expected after the company’s current blackout period and remains subject to market conditions and regulatory approvals. KXSCF +0.34% after hours to $89.9123. Source: Press Release More on Kinaxis Inc. Kinaxis Inc. 2025 Q3 - Results - Earnings Call Presentation Kinaxis Inc. (KXS:CA) Q3 2025 Earnings Call Transcript Kinaxis appoints Razat Gaurav as new CEO Seeking Alpha’s Quant Rating on Kinaxis Inc. Historical earnings data for Kinaxis Inc.
JHVEPhoto AMD ( AMD ) was in the spotlight on Wednesday after the semiconductor giant reported fourth-quarter results and guidance that were better-than-expected. However, a number of Wall Street firms had questions about the figures and said they were “not as positive as the print looked.” Shares fell 9% in premarket trading, while competitor Nvidia ( NVDA ) was fractionally positive. Wedbush Sec...
JHVEPhoto AMD ( AMD ) was in the spotlight on Wednesday after the semiconductor giant reported fourth-quarter results and guidance that were better-than-expected. However, a number of Wall Street firms had questions about the figures and said they were “not as positive as the print looked.” Shares fell 9% in premarket trading, while competitor Nvidia ( NVDA ) was fractionally positive. Wedbush Securities analyst Matt Bryson said the fourth-quarter data center revenue was aided by nearly $400M in unexpected MI308 revenue from China; however, the guidance calls for $100M in MI308 revenue calls from China, which was puzzling. “Net, even w/o the benefit of being able to writeup inventory, AMD's outlook in particular was better than consensus expectations,” Bryson wrote in a note to clients. “At the same time, with growing shortages of CPUs seemingly creating more opportunity to extract incremental value (higher volumes, more optimal mix, and price increases) that wasn't apparent in results or guidance, we can understand the post print sell-off in shares.” Bryson kept his Outperform rating and $290 price target on AMD. J.P. Morgan analyst Harlan Sur had a similar take, as he called the results and guidance a “mixed bag,” again referring to the ebb and flow of the China situation. “So, though Mar-Qtr guidance was also better than expected, the extent to which AMD is able to generate operating leverage remains in question and likely represents an overhang on the stock until this can be satisfactorily demonstrated (most likely 2H26), especially in light of risk to gross margins with the upcoming ramp of MI450/Helios later this year,” Sur wrote in a note to clients. He reiterated his Neutral rating and $270 price target on the stock. Regarding the China situation, AMD management—led by CEO Dr. Lisa Su and CFO Jean Hu—said it's a dynamic situation. The near $400M in revenue from China was from a license that was approved by the Trump Administration from orders “very early” in...
JHVEPhoto AMD ( AMD ) was in the spotlight on Wednesday after the semiconductor giant reported fourth-quarter results and guidance that were better-than-expected. However, a number of Wall Street firms had questions about the figures and said they were “not as positive as the print looked.” Shares fell 9% in premarket trading, while competitor Nvidia ( NVDA ) was fractionally positive. Wedbush Sec...
JHVEPhoto AMD ( AMD ) was in the spotlight on Wednesday after the semiconductor giant reported fourth-quarter results and guidance that were better-than-expected. However, a number of Wall Street firms had questions about the figures and said they were “not as positive as the print looked.” Shares fell 9% in premarket trading, while competitor Nvidia ( NVDA ) was fractionally positive. Wedbush Securities analyst Matt Bryson said the fourth-quarter data center revenue was aided by nearly $400M in unexpected MI308 revenue from China; however, the guidance calls for $100M in MI308 revenue calls from China, which was puzzling. “Net, even w/o the benefit of being able to writeup inventory, AMD's outlook in particular was better than consensus expectations,” Bryson wrote in a note to clients. “At the same time, with growing shortages of CPUs seemingly creating more opportunity to extract incremental value (higher volumes, more optimal mix, and price increases) that wasn't apparent in results or guidance, we can understand the post print sell-off in shares.” Bryson kept his Outperform rating and $290 price target on AMD. J.P. Morgan analyst Harlan Sur had a similar take, as he called the results and guidance a “mixed bag,” again referring to the ebb and flow of the China situation. “So, though Mar-Qtr guidance was also better than expected, the extent to which AMD is able to generate operating leverage remains in question and likely represents an overhang on the stock until this can be satisfactorily demonstrated (most likely 2H26), especially in light of risk to gross margins with the upcoming ramp of MI450/Helios later this year,” Sur wrote in a note to clients. He reiterated his Neutral rating and $270 price target on the stock. Regarding the China situation, AMD management—led by CEO Dr. Lisa Su and CFO Jean Hu—said it's a dynamic situation. The near $400M in revenue from China was from a license that was approved by the Trump Administration from orders “very early” in...
The woman had not previously pursued the claims because she was "not proud of the circumstances of that night," the letter says. "She was working as an exotic dancer, but she was treated like a prostitute."
The woman had not previously pursued the claims because she was "not proud of the circumstances of that night," the letter says. "She was working as an exotic dancer, but she was treated like a prostitute."
C1 Fund ( CFND ) has announced a share repurchase program in an aggregate amount of up to $3M. The share repurchase program will terminate on December 31, 2027. The fund has not previously repurchased any of its common shares. CFND +7.6% premarket at $4.79. More on C1 Fund Inc. C1 Fund Inc. reports Q3 results Seeking Alpha’s Quant Rating on C1 Fund Inc.
C1 Fund ( CFND ) has announced a share repurchase program in an aggregate amount of up to $3M. The share repurchase program will terminate on December 31, 2027. The fund has not previously repurchased any of its common shares. CFND +7.6% premarket at $4.79. More on C1 Fund Inc. C1 Fund Inc. reports Q3 results Seeking Alpha’s Quant Rating on C1 Fund Inc.
Sansert Sangsakawrat/iStock via Getty Images Amgen ( AMGN ) reported strong Q4 2025 results and provided full-year 2026 guidance that was above Street expectations. The company is managing losses of exclusivity on several large products quite well and it expects to deliver top and bottom-line growth in 2026 despite recent launches of biosimilar/generic versions of Prolia, Xgeva, and Ravicti. This ...
Sansert Sangsakawrat/iStock via Getty Images Amgen ( AMGN ) reported strong Q4 2025 results and provided full-year 2026 guidance that was above Street expectations. The company is managing losses of exclusivity on several large products quite well and it expects to deliver top and bottom-line growth in 2026 despite recent launches of biosimilar/generic versions of Prolia, Xgeva, and Ravicti. This is no small feat as these products generated approximately $7 billion in combined net sales last year. Achieving growth in 2026 will be possible due to the healthy existing product portfolio, new positive outcomes data of Repatha, and the recent label-expanding approvals for Uplizna. The new unknown and a risk for the 2026 outlook is the regulatory uncertainty on Tavneos – the European Medicines Agency (‘EMA’) initiated a review, and the FDA requested a withdrawal from the U.S. market due to clinical data integrity issues. Amgen’s initial reaction was to refuse to pull Tavneos from the market but I would acknowledge Tavneos’ market withdrawal as a realistic possibility. On the pipeline side, rocatinlimab was returned to partner Kyowa Kirin and the development of bemarituzumab will stop after last year's late-stage trial disappointments. These setbacks are countered by the mentioned outcomes data from Repatha, positive phase 2 results of daxdilimab, and the rapid progress of key obesity asset MariTide. Not a perfect picture, but overall, Amgen is making net progress and I continue to see it as well-positioned for long-term value creation even after a 20%+ share price increase since my September 2025 article . Strong end to 2025 with revenue and EPS exceeding expectations Amgen delivered 10% Y/Y revenue growth in Q4 2025 and slightly lower non-GAAP EPS of $5.29 (versus $5.31 in Q4 2024). Revenues were $440 million ahead of the Street consensus and non-GAAP EPS was $0.53 higher. Results look good even if we consider a $250 million inventory benefit across several products that...
The leading beverage company is a low-risk investment. Given how familiar investors might be with their products and services, it makes sense that consumer-facing businesses, as opposed to those that serve enterprise customers, are of interest. There might be worthwhile investment opportunities in this part of the stock market to consider. And these companies could be easier to understand. Coca-Co...
The leading beverage company is a low-risk investment. Given how familiar investors might be with their products and services, it makes sense that consumer-facing businesses, as opposed to those that serve enterprise customers, are of interest. There might be worthwhile investment opportunities in this part of the stock market to consider. And these companies could be easier to understand. Coca-Cola (KO +2.18%) is one of the most popular names that falls into this category. Could buying this beverage stock today set you up for life? Coca-Cola's brand supports its ongoing success It's clear why Coca-Cola has long been a top Warren Buffett holding. This business possesses one of the world's most valuable brands. Its products are loved across the globe. It has an endless list of offerings that can satisfy anyone's taste preferences. Broad distribution adds to visibility. And Coca-Cola has always had top-notch marketing expertise to resonate with consumers. The brand has stood the test of time. And this should give investors confidence that Coca-Cola will still dominate the beverage industry decades into the future. From a financial perspective, the brand helps Coca-Cola consistently raise prices. This supports durable growth, even though unit volumes don't increase by that much. What's more, the brand's strength flows to the income statement, helping to drive incredible profits. Coca-Cola's quarterly gross margin and quarterly operating margin averaged 61% and 27%, respectively, in the past 10 years. Investors benefit from the earnings stream because management returns lots of capital to shareholders. Coca-Cola's board of directors approved a $0.51 per share quarterly payout last February, marking the 63rd straight year that a dividend hike was implemented. Income investors will certainly appreciate this. Expand NYSE : KO Coca-Cola Today's Change ( 2.18 %) $ 1.65 Current Price $ 76.97 Key Data Points Market Cap $331B Day's Range $ 75.13 - $ 77.49 52wk Range $ 62.59 - $...
Nisian Hughes/DigitalVision via Getty Images Main Thesis Ponce Financial Group, Inc. ( PDLB ) valuation, as I will see, is mostly from its preferred stock redemption and elevated perpetual growth estimates. The company lacks solid profitability and, even with elevated capital ratios, has to decrease its riskiness due to elevated loan levels compared to its peers. The declining fiscal health of low...
Nisian Hughes/DigitalVision via Getty Images Main Thesis Ponce Financial Group, Inc. ( PDLB ) valuation, as I will see, is mostly from its preferred stock redemption and elevated perpetual growth estimates. The company lacks solid profitability and, even with elevated capital ratios, has to decrease its riskiness due to elevated loan levels compared to its peers. The declining fiscal health of low-income households, harsher business environments for small businesses, and political winds may slow the company’s growth, while bull scenarios are limited to an improbable improvement in the health of small businesses and low-income individuals, and/or multiple expansions. The Bank Ponce Financial Group is the bank holding for Ponce Bank, a Community Development Financial Institution (CDIF) and a Minority Depository Institution (MDI), giving loans predominantly to Small-Medium Sized Businesses (SMB) and Low-to-Moderate Income ( (LMI)) neighborhoods. The bank is headquartered in the Bronx, New York, and its loans are mostly given to individuals there and in Harlem. The bank was founded in 1960 by Puerto Rican migrants as a local savings association, and it currently holds $3.22 billion in assets, $2.60 billion in loans, and $2.05 billion in deposits, as stated in their latest 8-K filing . Preferred Stock Situation As mentioned in their 8-K, on December 20, 2024, Ponce Financial Group entered in an Emergency Capital Investment Program (ECIP) securities purchase option agreement with the US Department of the Treasury, allowing the company to repurchase the Preferred Shares at a steep discount. Currently, the preferred shares amount to $225 Million, and have a dividend of 0.5%. To be eligible for repurchase, the company needs at least 60% of its loans to be categorized as “deep impact” for at least 16 quarters. The company claims to have achieved an 82% rate of deep impact loans for 14 consecutive quarters, implying that the repurchase could occur as soon as 3Q 2026. In case t...
(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) initiated its adjusted earnings and sales growth guidance for the first quarter, and for the full-year 2026. For the first quarter, the company estimates adjusted earnings in a range of $0.78 to $0.80 per share on net sales growth of about 10.5 to 12.0 percent, w...
(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) initiated its adjusted earnings and sales growth guidance for the first quarter, and for the full-year 2026. For the first quarter, the company estimates adjusted earnings in a range of $0.78 to $0.80 per share on net sales growth of about 10.5 to 12.0 percent, with organic net sales growth of 8.5 to 10.0 percent. On average, analysts polled expect earnings of $0.80 per share on revenue growth of 11.57 percent to $5.20 billion for the quarter. Analysts' estimates typically exclude special items. Looking ahead to fiscal 2026, the company now projects adjusted earnings in a range of $3.43 to $3.49 per share on net sales growth of about 10.5 to 11.5 percent, with organic net sales growth of 10 to 11 percent. The Street is looking for earnings of $3.47 per share on revenue growth of 11.55 percent to $22.39 billion for the quarter. In Wednesday's pre-market trading, BSX is trading on the NYSE at $90.00, down $1.59 or 1.74 percent. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.